Journal of Medical Primatology

• 

  Publication Venue For

  • SUCCESSFUL DEVELOPMENT OF A NONHUMAN PRIMATE MODEL OF CONGENITAL CYTOMEGALOVIRUS TRANSMISSION.  43:426-426. 2014
  • TARGET CELL AVAILABILITY, RATHER THAN BREAST MILK SPECIFIC FACTORS, DICTATES MOTHER-TO-INFANT TRANSMISSION OF SIV.  43:385-385. 2014
  • STUDIES OF ENV-BASED RECOMBINANT IMMUNOGENS AND ROLE OF NEUTRALIZING ANTIBODY IN THE SIV MACAQUE MODEL.  40:269-270. 2011
  • MOSAIC VACCINES ELICIT CD8+T CELL RESPONSES IN MONKEYS THAT CONFER IMMUNE COVERAGE OF DIVERSE HIV STRAINS.  39:282-282. 2010
  • Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate..  34:226-236. 2005
  • Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration..  31:217-227. 2002
  • Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge..  31:109-119. 2002
  • DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus..  31:40-60. 2002
  • Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?.  30:190-196. 2001
  • Immunization against SIVmne in macaques using multigenic DNA vaccines..  28:206-213. 1999
  • Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm)..  28:97-104. 1999
  • The use of a urinary estrone conjugates assay for detection of optimal mating time in the cynomolgus macaque (Macaca fascicularis)..  20:229-234. 1991
  • Antibody-dependent enhancement of SIV infection: further characterization and cross reactivity between macaque and sooty mangabey isolates..  19:269-278. 1990
  • Uniocular vascular occlusion in a paraplegic hybrid monkey. A clinicopathologic study..  4:134-142. 1975
  • A new HIV/HBV co-infection model: hepatocytic expression of human sodium taurocholate cotransporting polypeptide (NTCP) Enables Hepatitis B Virus Infection of Macaques 2018
  • DNA and protein co-delivery vaccines using TLR-4-based adjuvants induce potent immune responses able to delay heterologous SIV acquisition 2018
  • Impact of a TLR-5 Ligand as Adjuvant on Immunogenicity and Efficacy of a RhCMV-SIV Vaccine 2018
  • Nonhuman primate models for Zika virus infection 2018
  • The optimization of pediatric vaccine regimens to prevent mother-to-child transmission of HIV through breast milk 2018
  • Effects of breast milk-derived non-broadly neutralizing antibodies on oral SHIV infection in infant rhesus monkeys 2017
  • Molecular patterns of SHIV Env-Ab coevolution in rhesus macaques recapitulate HIV-1 Env-Ab co-evolution in humans infected by HIV-1 strains bearing homologous Envs 2017
  • Molecular patterns of SHIV Env-Ab coevolution in rhesus macaques recapitulate HIV-1 Env-Ab co-evolution in humans infected by HIV-1 strains bearing homologous envs 2017
  • Mucin-binding IgG: Characterizing a novel antibody effector function and discovery of a new Fc receptor 2017
  • Pre-inoculation infusion with hyperimmune globulin protects against vertical transmission in the rhesus macaque model of congenital CMV infection 2017
  • DNA AND PROTEIN CO-IMMUNIZATION IMPROVES THE MAGNITUDE, LONGEVITY, AND MUCOSAL DISSEMINATION OF IMMUNE RESPONSES 2015
  • VACCINE-INDUCED MUCOSAL B CELLS ARE CORRELATED WITH DELAYED SIVMAC251 ACQUISITION FOLLOWING RECTAL CHALLENGE OF FEMALE BUT NOT MALE RHESUS MACAQUES 2015
  • HIV ENV-SPECIFIC IGG3 RESPONSES ARE DIFFERENTIALLY ELICITED IN NONHUMAN PRIMATE BY ENV VACCINES WITH DIFFERENT ADJUVANTS 2014
  • OPTIMIZATION OF SYSTEMIC AND MUCOSAL IMMUNE RESPONSES TO SIV AND HIV-1 ANTIGENS USING DIFFERENT PROTOCOLS OF DNA AND PROTEIN IMMUNIZATION IN MACAQUES 2014
  • PATHOGENICITY AND MUCOSAL TRANSMISSIBILITY OF R5-TROPIC SIMIAN/HUMAN IMMUNODEFICIENCY VIRUSES SHIVAD8 IN RHESUS MACAQUES: IMPLICATIONS FOR THEIR USE IN VACCINE STUDIES 2013
  • THE VAST MAJORITY OF RHESUS MACAQUES INFECTED WITH THE R5-TROPIC SHIVAD8 GENERATE CROSS-REACTIVE ANTIBODIES THAT NEUTRALIZE MULTIPLE HIV-1 STRAINS 2013
  • VACCINATION AGAINST MUCOSAL CHALLENGES WITH HETEROLOGOUS R5 CLADE C SHIV: PREVENTION OF INFECTION AND CORRELATES OF PROTECTION 2011
  • NATURAL EVOLUTION OF CLADE C SHIV NEUTRALIZATION SENSITIVITY FROM TIER 1 TO TIER 2 IS LINKED TO DIFFERENCES IN V1 AND V2 LOOP SEQUENCES IN ENV 2010
  • GM-CSF as an adjuvant for protective immune responses 2007
  • Identification of ENVS that preferentially bind the cross-reactive neutralizing Ab in chronic patient sera 2007
  • Mucosal aids vaccine delivered to rhesus macaques via immuno-stimulating complexes induces low levels of virus-neutralizing antibodies and cytotoxic T cell responses that are rapidly expanded upon challenge with simian-human immunodeficiency viruses (sHIVs) 2006